Geneoscopy Raises Crazy Money
"Thank you to our investors for recognizing the importance and the unmet need for more precise, noninvasive colorectal cancer (CRC) screening options like ours. This Series B funding enables us to bring our RNA technology to the fight to prevent colorectal cancer," read a post published by Geneoscopy on Linkedin.
"Another big milestone for Geneoscopy in our fight to prevent colorectal cancer! Couldn't be more proud of this team!" said Geneoscopy co-founder, Andrew Barnell, in a post on LinkedIn.
stLouIST